Eriodictyol suppresses the malignant progression of colorectal cancer by downregulating tissue specific transplantation antigen P35B (TSTA3) expression to restrain fucosylation

References

• Arnold M, Sierra MS, Laversanne M, et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683–691.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145–164.
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Qian CN, Mei Y, Zhang J. Cancer metastasis: issues and challenges. Chin J Cancer. 2017;36(1):38.
   PubMedGoogle Scholar
• Li ZN, Zhao L, Yu LF, et al. BRAF and KRAS mutations in metastatic colorectal cancer: future perspectives for personalized therapy. Gastroenterol Rep (Oxf). 2020;8(3):192–205.
   PubMed Web of Science ®Google Scholar
• Qadir MI. Role of green tea flavonoids and other related contents in cancer prevention. Crit Rev Eukaryot Gene Expr. 2017;27(2):163–171.
   PubMed Web of Science ®Google Scholar
• Yan YB, Tian Q, Zhang JF, et al. Antitumor effects and molecular mechanisms of action of natural products in ovarian cancer. Oncol Lett. 2020;20(5):141.
   PubMed Web of Science ®Google Scholar
• Imran M, Rauf A, Abu-Izneid T, et al. Luteolin, a flavonoid, as an anticancer agent: a review. Biomed Pharmacother. 2019;112:108612.
   PubMed Web of Science ®Google Scholar
• Rauf A, Imran M, Khan IA, et al. Anticancer potential of quercetin: a comprehensive review. Phytother Res. 2018;32(11):2109–2130.
   PubMed Web of Science ®Google Scholar
• Islam A, Islam MS, Rahman MK, et al. The pharmacological and biological roles of eriodictyol. Arch Pharm Res. 2020;43(6):582–592.
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen Y, Chen Y, et al. Eriodictyol inhibits IL-1β-induced inflammatory response in human osteoarthritis chondrocytes. Biomed Pharmacother. 2018;107:1128–1134.
   PubMed Web of Science ®Google Scholar
• Li W, Du Q, Li X, et al. Eriodictyol inhibits proliferation, metastasis and induces apoptosis of glioma cells via PI3K/Akt/NF-κB signaling pathway. Front Pharmacol. 2020;11:114.
   PubMed Web of Science ®Google Scholar
• Tang L, Qin Y, Ling K, et al. Eriodictyol inhibits the growth of CNE1 human nasopharyngeal cancer growth by targeting MEK/ERK signalling pathway, inducing cellular autophagy and inhibition of cell migration and invasion. J BUON. 2020;25(5):2389–2394.
   PubMed Web of Science ®Google Scholar
• Taniguchi N, Kizuka Y. Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics. Adv Cancer Res. 2015;126:11–51.
   PubMed Web of Science ®Google Scholar
• Cascio S, Finn OJ. Intra- and extra-cellular events related to altered glycosylation of MUC1 promote chronic inflammation, tumor progression, invasion, and metastasis. Biomolecules. 2016;6(4):39.
   PubMed Web of Science ®Google Scholar
• Du N, Song L, Li Y, et al. Phytoestrogens protect joints in collagen induced arthritis by increasing IgG glycosylation and reducing osteoclast activation. Int Immunopharmacol. 2020;83:106387.
   PubMed Web of Science ®Google Scholar
• Hao S, Fan Q, Bai Y, et al. Core fucosylation of intestinal epithelial cells protects against salmonella typhi infection via up-regulating the biological antagonism of intestinal microbiota. Front Microbiol. 2020;11:1097.
   PubMed Web of Science ®Google Scholar
• Shan M, Yang D, Dou H, et al. Fucosylation in cancer biology and its clinical applications. Prog Mol Biol Transl Sci. 2019;162:93–119.
   PubMed Web of Science ®Google Scholar
• Iwona R, Katarzyna S. Glycosylation of proteins of human skin fibroblasts is changed by rosmarinic acid. Naunyn Schmiedebergs Arch Pharmacol. 2020;393(3):419–427.
   PubMed Web of Science ®Google Scholar
• Gao Y, Zhang G, Liu J, et al. Tissue-specific transplantation antigen P35B functions as an oncogene and is regulated by microRNA-125a-5p in lung cancer. Oncol Rep. 2021;45(5):72.
   PubMed Web of Science ®Google Scholar
• Yang J, Kong P, Yang J, et al. High TSTA3 expression as a candidate biomarker for poor prognosis of patients with ESCC. Technol Cancer Res Treat. 2018;17:1533033818781405.
   Web of Science ®Google Scholar
• Sun Y, Liu X, Zhang Q, et al. Oncogenic potential of TSTA3 in breast cancer and its regulation by the tumor suppressors miR-125a-5p and miR-125b. Tumour Biol. 2016;37(4):4963–4972.
   PubMedGoogle Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Tseng JY, Yang CY, Liang SC, et al. Interleukin-17A modulates circulating tumor cells in tumor draining vein of colorectal cancers and affects metastases. Clin Cancer Res. 2014;20(11):2885–2897.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang R, Ni H. Eriodictyol exerts potent anticancer activity against A549 human lung cancer cell line by inducing mitochondrial-mediated apoptosis, G2/M cell cycle arrest and inhibition of m-TOR/PI3K/Akt signalling pathway. Arch Med Sci. 2020;16(2):446–452.
   PubMed Web of Science ®Google Scholar
• Veillon L, Fakih C, Abou-El-Hassan H, et al. Glycosylation changes in brain cancer. ACS Chem Neurosci. 2018;9(1):51–72.
   PubMed Web of Science ®Google Scholar
• Ma TX, Zhang L, Xu L, et al. Mitigation of isoquercitrin on β-lactoglobulin glycation: insight into the mechanisms by mass spectrometry and interaction analysis. Int J Biol Macromol. 2020;155:1133–1141.
   PubMed Web of Science ®Google Scholar
• Liu F, Xu K, Xu Z, et al. The small molecule luteolin inhibits N-acetyl-α-galactosaminyltransferases and reduces mucin-type O-glycosylation of amyloid precursor protein. J Biol Chem. 2017;292(52):21304–21319.
   PubMed Web of Science ®Google Scholar
• Fang R, Xu F, Shi H, et al. LAMTOR5 raises abnormal initiation of O-glycosylation in breast cancer metastasis via modulating GALNT1 activity. Oncogene. 2020;39(11):2290–2304.
   PubMed Web of Science ®Google Scholar
• Liu HM, Ma LL, Cao B, et al. Progress in research into the role of abnormal glycosylation modification in tumor immunity. Immunol Lett. 2021;229:8–17.
   PubMed Web of Science ®Google Scholar
• Bastian K, Scott E, Elliott DJ, et al. FUT8 alpha-(1,6)-fucosyltransferase in cancer. Int J Mol Sci. 2021;22(1):455.
   PubMed Web of Science ®Google Scholar
• Xu J, Xiao Y, Liu B, et al. Exosomal MALAT1 sponges miR-26a/26b to promote the invasion and metastasis of colorectal cancer via FUT4 enhanced fucosylation and PI3K/Akt pathway. J Exp Clin Cancer Res. 2020;39(1):54.
   PubMed Web of Science ®Google Scholar
• Kizuka Y, Nakano M, Yamaguchi Y, et al. An alkynyl-fucose halts hepatoma cell migration and invasion by inhibiting GDP-fucose-synthesizing enzyme FX, TSTA3. Cell Chem Biol. 2017;24(12):1467–1478.e5.
   PubMed Web of Science ®Google Scholar
• Zhang L, Gao Y, Zhang X, et al. TSTA3 facilitates esophageal squamous cell carcinoma progression through regulating fucosylation of LAMP2 and ERBB2. Theranostics. 2020;10(24):11339–11358.
   PubMed Web of Science ®Google Scholar